Ardelyx
ARDX
₹450.16
Share price
16.86%
Change (1 day)
-8.08%
Change (1 year)
Categories
Earnings for Ardelyx (ARDX)
Earnings in 2025 (TTM): -₹4.48 Billion
According to Ardelyx's latest financial reports the company's current earnings are ₹0.36 Billion. In 2024 the company made an earning of -₹3.42 Billion, an increase over its 2023 earnings that were of -₹5.75 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Ardelyx from 2013 to 2025
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2025 (TTM)  | -₹4.48 Billion | 31.11% |
| 2024 | -₹3.42 Billion | -40.67% |
| 2023 | -₹5.75 Billion | -2.5% |
| 2022 | -₹5.9 Billion | -57.51% |
| 2021 | -₹13.88 Billion | 67.7% |
| 2020 | -₹8.28 Billion | -0.34% |
| 2019 | -₹8.31 Billion | 3.66% |
| 2018 | -₹8.02 Billion | 44.54% |
| 2017 | -₹5.55 Billion | -43.8% |
| 2016 | -₹9.87 Billion | 279.04% |
| 2015 | -₹2.61 Billion | 841.87% |
| 2014 | -₹0.28 Billion | -50.99% |
| 2013 | -₹0.57 Billion |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | -₹48.62 Million | -98.95% | 🇺🇸 USA |
 Amgen AMGN | ₹583.53 B | -12,704.72% | 🇺🇸 USA |
 Sanofi SNY | ₹769.48 B | -16,721.33% | 🇫🇷 France |
 Abbott Laboratories ABT | ₹693.04 B | -15,070.24% | 🇺🇸 USA |
 AstraZeneca AZN | ₹1.026 T | -22,271.05% | 🇬🇧 UK |